This early event contributes to the two-hit inactivation of key tumor-suppressive loci, particularly VHL, thereby initiating the molecular cascade that drives ccRCC development (Hu et al., 2024). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.